Fatal pulmonary hemorrhage after taking anticoagulation medication
We describe a 64-year-old man with extensive diffuse acute lung hemorrhage, presumably as a result of anticoagulation therapy. We evaluated reports in the literature concerning acute exacerbation (acute lung injury of unknown cause) in UIP and other forms of fibrotic interstitial pneumonias. We also...
Main Author: | |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2015-01-01
|
Series: | Respiratory Medicine Case Reports |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2213007115000441 |
_version_ | 1831707095134633984 |
---|---|
author | Samuel P. Hammar |
author_facet | Samuel P. Hammar |
author_sort | Samuel P. Hammar |
collection | DOAJ |
description | We describe a 64-year-old man with extensive diffuse acute lung hemorrhage, presumably as a result of anticoagulation therapy. We evaluated reports in the literature concerning acute exacerbation (acute lung injury of unknown cause) in UIP and other forms of fibrotic interstitial pneumonias. We also evaluated autopsy tissue in this case in order to determine the cause of death in this 64-year-old man, who was initially thought to have an asbestos-related disease. Based on the autopsy findings, this man died as a result of anticoagulation therapy; specifically, the use of Xarelto® (rivaroxaban). |
first_indexed | 2024-12-20T18:11:39Z |
format | Article |
id | doaj.art-0a0200dfbef24c6688e3ece4cc87fa4a |
institution | Directory Open Access Journal |
issn | 2213-0071 |
language | English |
last_indexed | 2024-12-20T18:11:39Z |
publishDate | 2015-01-01 |
publisher | Elsevier |
record_format | Article |
series | Respiratory Medicine Case Reports |
spelling | doaj.art-0a0200dfbef24c6688e3ece4cc87fa4a2022-12-21T19:30:27ZengElsevierRespiratory Medicine Case Reports2213-00712015-01-0115C667010.1016/j.rmcr.2015.05.010Fatal pulmonary hemorrhage after taking anticoagulation medicationSamuel P. HammarWe describe a 64-year-old man with extensive diffuse acute lung hemorrhage, presumably as a result of anticoagulation therapy. We evaluated reports in the literature concerning acute exacerbation (acute lung injury of unknown cause) in UIP and other forms of fibrotic interstitial pneumonias. We also evaluated autopsy tissue in this case in order to determine the cause of death in this 64-year-old man, who was initially thought to have an asbestos-related disease. Based on the autopsy findings, this man died as a result of anticoagulation therapy; specifically, the use of Xarelto® (rivaroxaban).http://www.sciencedirect.com/science/article/pii/S2213007115000441Acute lung hemorrhageAnticoagulation therapyXarelto®Rivaroxaban |
spellingShingle | Samuel P. Hammar Fatal pulmonary hemorrhage after taking anticoagulation medication Respiratory Medicine Case Reports Acute lung hemorrhage Anticoagulation therapy Xarelto® Rivaroxaban |
title | Fatal pulmonary hemorrhage after taking anticoagulation medication |
title_full | Fatal pulmonary hemorrhage after taking anticoagulation medication |
title_fullStr | Fatal pulmonary hemorrhage after taking anticoagulation medication |
title_full_unstemmed | Fatal pulmonary hemorrhage after taking anticoagulation medication |
title_short | Fatal pulmonary hemorrhage after taking anticoagulation medication |
title_sort | fatal pulmonary hemorrhage after taking anticoagulation medication |
topic | Acute lung hemorrhage Anticoagulation therapy Xarelto® Rivaroxaban |
url | http://www.sciencedirect.com/science/article/pii/S2213007115000441 |
work_keys_str_mv | AT samuelphammar fatalpulmonaryhemorrhageaftertakinganticoagulationmedication |